Bruno Sangro

University Name

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

ORCID

Google Scholar

Articles (11)

Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial

Article Link

Year:

2023

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

Article Link

Year:

2023

Combination immunotherapy for hepatocellular carcinoma

Article Link

Year:

2023

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD

Article Link

Year:

2023

Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)

Article Link

Year:

2023

Transarterial Radioembolization Ought Not to Borrow Future Liver Function from Patients with Hepatocellular Carcinoma. But Does It?

Article Link

Year:

2023

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment

Article Link

Year:

2023

Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study

Article Link

Year:

2023

In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis

Article Link

Year:

2023

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association

Article Link

Year:

2022

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma

Article Link

Year:

2022

Collaborators (6)

Mariano Ponz-Sarvise

Universidad de Navarra

SPAIN

Aiwu He

Associate Professor

Georgetown University

UNITED STATES

Helen Reeves

Professor of Liver Cancer

Newcastle University

UNITED KINGDOM

Josepmaria Argemi

Adjunct Assistant Professor

University of Pittsburgh

UNITED STATES

Daniel Aliseda Jover

Clinica Universidad de Navarra

SPAIN

Lorenza Rimassa

Humanitas University

ITALY

Bruno Sangro

Research Interests

Explore related searches

Contact this professor

Articles (11)

Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

Combination immunotherapy for hepatocellular carcinoma

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD

Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)

Transarterial Radioembolization Ought Not to Borrow Future Liver Function from Patients with Hepatocellular Carcinoma. But Does It?

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment

Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study

In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma

Collaborators (6)

Mariano Ponz-Sarvise

Aiwu He

Helen Reeves

Josepmaria Argemi

Daniel Aliseda Jover

Lorenza Rimassa

How do I reach out?

Meet Kite AI